Latest Keystone Financial Ad One year ago this month, KeyStone’s first BUY recommendation following our November 2023 Live Webinars was VitalHub (VHI:TSX), a cash-rich, completely unknown but very profitable health-related software stock.
How has VitalHub, a stock no Big Bank analyst even had a rating on, performed over the past 12-months?
VitalHub (VHI:TSX) jumps 216%, ranking it as one of the best performing stocks on the entire Toronto Stock Exchange over the past year!
Recommended: November 2023, at $3.24
Today’s Price: $10.25
Gain: 216%
VitalHub (VHI:TSX), is a solid growth, Canadian healthcare software company. KeyStone followed VitalHub and interviewed management for years but monitored the stock for an attractive entry point. In late August 2023, we identified an inflection point in the business and recommended clients BUY at a price of $3.24. Just 12-months after our initial recommendation the stock has jumped 216% to $10.25, driven by strong cash flow generation and record revenue growth as well as several smart acquisitions including its largest ever announced just last week.
The company is another excellent example of KeyStone’s discovery style research into profitable, cash producing growth stocks that are just not covered by the Big Banks.